HEALTH

Former Asteres CEO joins H. D. Smith

BY Michael Johnsen

SPRINGFIELD, Ill. — H. D. Smith, the fourth-largest national pharmaceutical wholesaler, on Tuesday named Mark de Bruin to the post of corporate VP managed care.

In his new position at H. D. Smith, 29-year industry veteran de Bruin will be responsible for the company’s third party network, creating and maintaining an alliance of prescription and healthcare service providers.

"Our third party network is one of the many solutions H. D. Smith developed to address efficiency and reimbursement demands facing community pharmacies," Chris Smith, H. D. Smith COO Chris Smith said. "Mark’s retail pharmacy experience, cultivated at Rite Aid, together with his significant managed care and pharmacy government affairs acumen will spark growth and development of the network to the benefit of our customers."

De Bruin most recently served as CEO at Asteres, providing patented automated technology solutions to retail pharmacies, grocery stores, hospitals and the military. De Bruin served at Rite Aid as EVP pharmacy; Albertsons/American Stores as VP pharmacy and managed care; and RxAmerica/American Stores as president and GM.

De Bruin is a registered pharmacist in Utah, Pennsylvania and California. He earned a bachelor of science degree in pharmacy from the University of Utah. De Bruin also has served on numerous industry boards, including the Federal Medicaid Commission.

keyboard_arrow_downCOMMENTS

Leave a Reply

N.OYOLA says:
Jul-05-2011 12:14 pm

Congratulations.

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

FDA issues new dietary ingredient guidance

BY Michael Johnsen

WASHINGTON — The Food and Drug Administration on Tuesday published long-awaited guidance on new dietary ingredients in the Federal Register.

Once enacted, the guidance will establish an additional pillar of credibility to the dietary supplement industry, adding to the veracity building across the industry with the implementation of a codified, supplement-specific good manufacturing practices; the adoption of the mandatory reporting of serious adverse event reports; industry efforts to educate lawmakers and healthcare professionals around the benefits of supplementation; and an industry-sponsored initiative with the National Advertising Division of the Better Business Bureau to help the industry self-regulate inaccurate advertising claims.

Specifically, the guidance establishes a protocol around when a supplement manufacturer must file a premarket safety notification of a dietary supplement containing a new dietary ingredient. The guidance addresses in question-and-answer format what qualifies as an NDI, when an NDI notification is necessary, the procedures for submitting an NDI notification, the types of data and information that the FDA recommends manufacturers and distributors consider when they evaluate the safety of a dietary supplement containing an NDI, and what should be included in an NDI notification. In addition, the guidance contains questions and answers about parts of the dietary supplement definition that can affect whether a particular substance may be marketed as a dietary ingredient in a dietary supplement.

“The dietary supplement industry has eagerly awaited this guidance in the hope that it will provide clarity and an appropriate framework for introducing new ingredients and products into the supplement marketplace,” Council for Responsible Nutrition president and CEO Steve Mister said. “This draft guidance … represent[s] an important step for the dietary supplement industry — and for the agency — as it demonstrates further implementation of the requirements of the Dietary Supplement Health and Education Act and will give companies clearer understanding of [the] FDA’s expectations under the law.”

To help explain the nuances of the new guidance for the industry, the Natural Products Association will host a webinar conference on July 11. Speakers will include Daniel Fabricant, director of the Division of Dietary Supplement Programs at the FDA’s Center for Food Safety and Applied Nutrition; Scott Bass, head of the Global Life Sciences Team at Sidley Austin; Cara Welch, Natural Products Association VP scientific and regulatory affairs; and John Gay, Natural Products Association executive director and CEO. To join the call register here.

Review the draft guidance here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Vitamin D explodes with product growth

BY Amanda Baltazar


The vitamin D category continues to grow. Category leader Nature Made from Pharmavite is on the cusp of launching a host of new products, including a Super D-Complex with magnesium, vitamin D chewable tablets and vitamin D with vitamin C and zinc.


“I think this is category growth that has been driven by the science,” said Doug Jones, Pharmavite’s corporate communications and public relations manager. “When you get a lot of the medical establishment behind it, you see long-term sustained growth of a category. And vitamin D has received lots of press. There’s widespread recognition that there’s a deficiency problem.”


John Hathcock, SVP scientific and international affairs for the Council for Responsible Nutrition, said that the information about vitamin D is permeating the public’s awareness because it’s so all-encompassing. “For well over 50 years and perhaps closer to 75, we’ve known that vitamin D aids in the absorption of calcium and thus [helps to] build healthy bones,” Hathcock said. “But it’s also been found to help reduce the risk of cancer, hypertension and cardiovascular disease, diabetes and other metabolic syndrome issues, [and] falls related to neuromuscular activity, [as well as] immune function and all the things that result from that.”


The numbers back up the science. Sales of vitamin D were up 49% for the 52 weeks ended April 16, down slightly from last December when sales were up 73%, according to Nielsen.


Despite Pharmavite having a plethora of vitamin D products, its best-seller remains its 1,000 IU product. Also, last year the company released a product with 5,000 IU, and two years ago it launched a 400-IU chewable vitamin D product for children.


Hathcock said he expected to see more vitamin D supplements on the market — from multivitamins with vitamin D to vitamin D and calcium tablets. But with a marketplace as full as it is with new vitamin D products, how does Pharmavite ensure its products stand out? The company participates in the dietary supplement program from the United States Pharmacopeia, a scientific not-for-profit organization that has set pharmaceutical quality standards since 1820 and bears the USP’s stamp on many of its products, with more constantly being added.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?